Manages pain severe enough to require an opioid analgesic. ANDA 75824, held by Hikma. Butorphanol Tartrate.
As of Nov 16, 2026, ANDA 75824 (Butorphanol Tartrate), held by Hikma, was first approved by FDA on Mar 12, 2002, with 11 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Butorphanol Tartrate Nasal Spray is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy, reserve opioid analgesics, including Butorphanol Tartrate Nasal Spray, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 12, 2002 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butorphanol Tartrate1MG/SPRAY · spray, metered;nasal | Butorphanol Tartrate | Rx |
| Jun 18, 2026 | Supplement 23REMS | Approved | None posted |
| Dec 22, 2025 | Supplement 20Labeling · Standard review | Approved | None posted |
| Dec 22, 2025 | Supplement 22Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 21REMS | Approved | None posted |
| Dec 15, 2023 | Supplement 19Labeling · Standard review | Approved | None posted |
| Mar 4, 2021 | Supplement 14Labeling · Standard review | Approved | None posted |
| Oct 7, 2019 | Supplement 13Labeling · Standard review | Approved | None posted |
| Sep 21, 2018 | Supplement 12Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 11REMS | Approved | None posted |
| Mar 23, 2017 | Supplement 9Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 8Labeling · Standard review | Approved | None posted |
| Mar 12, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters